These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3727064)

  • 21. [Clinical use of ajmaline].
    Fomina IG
    Klin Med (Mosk); 1973 Nov; 51(11):9-15. PubMed ID: 4132418
    [No Abstract]   [Full Text] [Related]  

  • 22. [Jaundice caused by ajmaline: pathogenetic theory concerning 5 cases].
    Giani E; Cestari C; Lomazzi A; Magni S; Pioltelli P; Ratti L; Dinelli CA
    Clin Ter; 1981 Oct; 99(2):155-64. PubMed ID: 7318369
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug-fever due to ajmaline (Tachmalin)].
    Tausche P; Wunderlich E
    Z Gesamte Inn Med; 1976 Mar; 31(5):153-5. PubMed ID: 936705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preventive treatment of arrhythmias with di-monochloroacetyl-ajmaline (DCAA)].
    Mancuso M; Salazzari GC; Cicogna F; Zanini S
    Minerva Cardioangiol; 1973; 21(7):513-20. PubMed ID: 4756346
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ajmaline-induced plasmacytosis with pancytopenia].
    Matsuo T; Kawano F; Yonemura Y; Nomura H; Takatsuki K
    Rinsho Ketsueki; 1987 Mar; 28(3):418-22. PubMed ID: 3613129
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anuria, cholestatic jaundice, thrombocytopenia, hemolysis. Immunoallergic complication due to ajmaline].
    Faller JP; Simon G; Rodier L; Cazenave JP
    Ann Med Interne (Paris); 1985; 136(5):386-8. PubMed ID: 4062136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral administration of N-propyl-ajmaline bitartrate in heart rhythm disorders].
    Böttcher D; Nissen P; Harmjanz D
    Med Klin; 1972 Jun; 67(24):855-9. PubMed ID: 4116006
    [No Abstract]   [Full Text] [Related]  

  • 28. [Toxic liver damage caused by ajmaline].
    Stránský J; Velan J; Kostrhun L; Michálková D; Vozenílek J; Vodák M
    Vnitr Lek; 1985 Dec; 31(12):1208-12. PubMed ID: 4090309
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recurrent anuria, thrombopenia and jaundice: unusual manifestation of hypersensitivity to ajmaline].
    Guyon B; Perol C; Herve P; Dupond JL; Leconate des Floris R
    Nouv Presse Med; 1978 May; 7(18):1558. PubMed ID: 673706
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of atrial fibrillation in patients with Wolff-Parkinson-White syndrome using ajmaline and quinidine].
    García Civera R; Sanjuán Mañez R; Rodríguez Serra M; García-Sacritán J; Morell Cabedo S; Llavador Sanchis J
    Rev Esp Cardiol; 1982; 35(3):277-84. PubMed ID: 7134591
    [No Abstract]   [Full Text] [Related]  

  • 31. [Value of the ajmaline test. Apropos of 1170 cases].
    Perrot B; Aliot E; Gilgenkrantz JM; Cherrier F; Faivre G
    Ann Cardiol Angeiol (Paris); 1982; 31(6):435-41. PubMed ID: 7158990
    [No Abstract]   [Full Text] [Related]  

  • 32. Stress testing of distal conduction by intravenous ajmaline.
    Khalilullah M; Sathyamurthy I; Gambhir DS; Bahl VK
    Indian Heart J; 1986; 38(1):15-21. PubMed ID: 3744400
    [No Abstract]   [Full Text] [Related]  

  • 33. [Liver damage in connection with ajmaline treatment].
    Einarsson K; Hellström K; Kallner M
    Lakartidningen; 1973 Mar; 70(13):1288-90. PubMed ID: 4699013
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ajmaline induced hepatitis in Denmark].
    Rubinstein E; Dejgård A; Duus B
    Ugeskr Laeger; 1981 Nov; 143(49):3304-5. PubMed ID: 7331043
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute renal insufficiency and ajmaline].
    Godin M; Moulin B; Sery D; Fillastre JP
    Ann Med Interne (Paris); 1986; 137(2):167. PubMed ID: 3717822
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
    Gullion G; Yeh HS
    J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary clinical studies on the antiparkinson effects of 17-monochloroacetylajmaline].
    Errichiello G; Maglione S
    Minerva Med; 1974 May; 65(41):2357-9. PubMed ID: 4602984
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug-induced agranulocytosis: response to treatment].
    Campodarve I; Mínguez S; Knobel H; Supervía A
    Med Clin (Barc); 1993 May; 100(18):717. PubMed ID: 8492603
    [No Abstract]   [Full Text] [Related]  

  • 39. Pentazocine-induced agranulocytosis.
    Haibach H; Yesus YW; Doggett JJ
    Can Med Assoc J; 1984 May; 130(9):1165-6. PubMed ID: 6713337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Agranulocytosis during treatment with salicylazosulfapyridine (Salazopyrin)].
    Marstein S
    Tidsskr Nor Laegeforen; 1969 Oct; 89(19):1484-7. PubMed ID: 4392789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.